[HTML][HTML] Risk and protective factors for COVID-19 morbidity, severity, and mortality

J Zhang, X Dong, G Liu, Y Gao - Clinical reviews in allergy & immunology, 2023 - Springer
The outbreak of the coronavirus disease 2019 (COVID-19), caused by the novel severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become an evolving global …

Disparities in COVID-19 outcomes by race, ethnicity, and socioeconomic status: a systematic review and meta-analysis

S Magesh, D John, WT Li, Y Li… - JAMA network …, 2021 - jamanetwork.com
Importance COVID-19 has disproportionately affected racial and ethnic minority groups, and
race and ethnicity have been associated with disease severity. However, the association of …

[HTML][HTML] A systematic review of racial/ethnic and socioeconomic disparities in COVID-19

A Khanijahani, S Iezadi, K Gholipour… - International journal for …, 2021 - Springer
Background Preliminary evidence from the COVID-19 pandemic shows the presence of
health disparities, especially in terms of morbidity and mortality. This study aimed to …

COVID-19 and cardiovascular disease: from bench to bedside

MK Chung, DA Zidar, MR Bristow, SJ Cameron… - Circulation …, 2021 - Am Heart Assoc
A pandemic of historic impact, coronavirus disease 2019 (COVID-19) has potential
consequences on the cardiovascular health of millions of people who survive infection …

Stroke in patients with COVID-19: Clinical and neuroimaging characteristics

A Vogrig, GL Gigli, C Bna, M Morassi - Neuroscience letters, 2021 - Elsevier
Acute cerebrovascular disease, particularly ischemic stroke, has emerged as a serious
complication of infection by the severe acute respiratory syndrome coronavirus 2 (SARS …

Trends in patient characteristics and COVID-19 in-hospital mortality in the United States during the COVID-19 pandemic

GA Roth, S Emmons-Bell, HM Alger… - JAMA network …, 2021 - jamanetwork.com
Importance In-hospital mortality rates from COVID-19 are high but appear to be decreasing
for selected locations in the United States. It is not known whether this is because of …

A policy prescription for reducing health disparities—achieving pharmacoequity

UR Essien, SB Dusetzina, WF Gellad - Jama, 2021 - jamanetwork.com
In 2019, the US spent $3.8 trillion on health care, including an estimated $370 billion on
retail prescription drugs alone. 1 Onaverage, individualsintheUSspendmorethan $1100 per …

Association between COVID-19 diagnosis and in-hospital mortality in patients hospitalized with ST-segment elevation myocardial infarction

M Saad, KF Kennedy, H Imran, DW Louis, E Shippey… - Jama, 2021 - jamanetwork.com
Importance There has been limited research on patients with ST-segment elevation
myocardial infarction (STEMI) and COVID-19. Objective To compare characteristics …

Health care disparities during the COVID-19 pandemic

EA Andraska, O Alabi, C Dorsey, Y Erben… - Seminars in vascular …, 2021 - Elsevier
ABSTRACT Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2, is a pandemic with more than 32 million cases and more than …

Hypertension, a moving target in COVID-19: current views and perspectives

C Savoia, M Volpe, R Kreutz - Circulation Research, 2021 - Am Heart Assoc
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) associates with a considerable high rate of mortality and …